February 26, 2018 by Geoff Walden and Chain Drug Review
Affordable Care Act, Avalere, CHRONIC Act, CREATES Act, Daniel Mendelson, federal budget legislation, health care spending, Independent Payment Advisory Board, Medicare Part D, Pharmaceutical Research and Manufacturers of America, Stephen Ubl
2018, Issue 02-26-2018, Issues, Leading Headlines, News, Pharmacy, Retail News

WASHINGTON — Health care spending has been beefed up in some areas and reduced in others as a result of the federal budget legislation passed by Congress earlier this month. Chronic care funding was bolstered by the two-year spending plan, which was signed into law by President Trump, while some Affordable Care Act appropriations were
October 19, 2016 by Chain Drug Review
Chip Davis, generic drugs, Generic Pharmaceutical Association, generic prescription drugs, GPhA, GPhA's 2016 Generic Drug Savings and Access in the United States report, health care spending, QuintilesIMS Institute, U.S. drug spending
Leading Headlines, Pharmacy, Retail News

WASHINGTON — Annual health care savings from generic prescription drugs rose nearly 10% last year to $227 billion, according to the Generic Pharmaceutical Association (GPhA). GPhA’s 2016 Generic Drug Savings and Access in the United States report, released Wednesday, tallied the 10-year national savings for generics at $1.46 trillion, representing a gain of 328% from
August 8, 2016 by CDR Blog and Chain Drug Review
health care spending, PhRMA, prescription drug spending, Prescription Medicines: Costs In Context
CDR Blog

The updated “Prescription Medicines: Costs In Context” report from the Pharmaceutical Research and Manufacturers of America (PhRMA) gives both a surprising and not-so-suprising snapshot of the changing Rx marketplace and how the nation’s health system is adapting. More than 7,000 medications are in development worldwide, led by drugs for cancer (1,813), neurological disorders (1,329), infectious
May 16, 2016 by Scot Meyer and Chain Drug Review
Covered Outpatient Drugs final rule, H-E-B, health care spending, Hy-Vee, Martin Otto, NACDS, NACDS Annual Meeting, National Association of Chain Drug Stores, Randy Edeker, RxImpact Day, U.S. health care industry
2016, Issue 05-16-2016, Issues, News

PALM BEACH, Fla. — The U.S. health care system is not functioning in a sustainable way, new National Association of Chain Drug Stores chairman Martin Otto said at the organization’s Annual Meeting here last month. Costs are too high and are rising fast, while outcomes are disappointing. “There are a number of structural issues in
April 4, 2016 by Chain Drug Review
Harry Leider, health care spending, medication adherence, medication therapy management, Michael Taitel, MTM, Population Health Management, Walgreens, Walgreens community pharmacists
Leading Headlines, Pharmacy, Retail News

DEERFIELD, Ill. — A new study from Walgreens Boots Alliance Inc. indicates that pharmacy interventions can lead to greater medication adherence and lower health care costs. The study, titled “Improving Medication Adherence and Health Care Outcomes in a Commercial Population Through a Community Pharmacy,” was published in a recent issue of Population Health Management. The
March 18, 2016 by CDR Blog
Health Affairs, health and wellness, health care spending, Oliver Wyman, retail clinic
CDR Blog

A pair of new studies shed some light on the use of retail clinics and their potential as an alternative site for health care. With the push to rein in health care costs for both consumers and payers, retail clinics have been seen as a more affordable option to doctor’s office and emergency room visits.
December 7, 2015 by John Schultz and Chain Drug Review
Affordable Care Act, Andrew Slavitt, Centers for Medicare & Medicaid Services, health care spending, health insurance coverage, Medicaid, spending on prescription drugs
2015, Business, Issue 12-07-2015, Issues, Leading Headlines, Pharmacy, Retail News

WASHINGTON — Health care spending in the United States last year exceeded $3 trillion as five years of slow growth was replaced by the Affordable Care Act’s expansion of Medicaid and private health insurance coverage. Prescription drug prices accelerated as well. Health care spending grew faster than the economy in 2014, and the federal share
September 28, 2015 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, health care costs, health care reform, health care spending, J. Samantha Dougherty, Jeffrey Woldt, Laura Miller, National Association of Chain Drug Stores, Pharmaceutical Research and Manufacturers of America, retail pharmacies
2015, Issue 09-28-2015, Issues, Opinion

The major provisions of the Patient Protection and Affordable Care Act have been in effect for almost two years now, enough time to undertake an interim analysis of the controversial law’s impact on the health care system. President Obama and other advocates of the ACA, which since its enactment in March 2010 has withstood two
March 16, 2015 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, Department of Health and Human Services, health care reform, health care spending, HealthCare.gov, Jeffrey Woldt, King v. Burwell
2015, Issue 03-16-2015, Opinion
Although the Affordable Care Act was signed into law by President Obama five years ago and the major provisions of the legislation took effect at the beginning of 2014, health care reform remains a highly contentious work in progress. Two recent reports provide some indications about the ACA’s success to date in achieving its primary